Target intelligence / Profile preview

NOL11 pseudogene 1

Molecular classification
Pseudogene, Non-coding RNA
01

Overview

NOL11 pseudogene 1 denotes a genomic sequence that is highly similar to the NOL11 gene but is considered a non-functional, non-protein-coding pseudogene. Pseudogenes arise by gene duplication or retrotransposition events and often possess disabling mutations that preclude RNA/protein production or function[4][7]. While some pseudogenes are transcribed and can have regulatory roles via their RNA, there is no established evidence that NOL11 pseudogene 1 produces a functional RNA or participates in gene regulation or disease. Its parental gene, NOL11 (Nucleolar protein 11), is a protein-coding gene involved in ribosomal RNA processing and nucleolar function[1]. No evidence exists for NOL11 pseudogene 1 being a receptor, enzyme, transporter, or any established drug target. Key clarification: - NOL11 pseudogene 1 is *not* a receptor, enzyme, or druggable target, and the entry likely reflects a misinterpretation or a non-functional genomic feature, not an established therapeutic asset[4][7]. - If you are seeking data on the functional gene, refer to Nucleolar protein 11 (NOL11)[1]. - Most pseudogenes, including this one, are not drug targets but may have minor regulatory functions or could be transcribed, though these are very rarely clinically actionable.

Beyond the preview

Go deeper on NOL11 pseudogene 1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NOL11 pseudogene 1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call